Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Qatar.
Campus
Campus

EVOLUTION: RWE from Saudi Arabia

Evaluating the clinical effectiveness and safety of insulin glargine 300 U/ml in individuals with T2D uncontrolled on Basal insulin: A real-world evidence study form Saudi Arabia (EVOLUTION).

Related articles
EMPOWER Study in Saudi Arabia

EMPOWER Study in Saudi Arabia

Key highlights from the EMPOWER Study in Saudi Arabia

Read article
Glargine 300 use in people with type 2 diabetes who fast during Ramadan
  • Diabetes

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Watch Professor Mohamed Hassanein, consultant endocrinologist in Dubai Hospital, Dubai Health Authority and the chair of Diabetes and Ramadan International Alliance shedding the light on what are the unmet needs amongst Muslims with Type 2 diabetes when fast during Ramadan.

Read article
Challenges associated with commonly-used insulin advancement options
  • Diabetes

Challenges associated with commonly-used insulin advancement options

Read article
MAT-BH-2300744/V1/NOV2023